Regional arterial infusion with lipoxin A4 attenuates experimental severe acute pancreatitis

PLoS One. 2014 Sep 29;9(9):e108525. doi: 10.1371/journal.pone.0108525. eCollection 2014.

Abstract

Objective: Investigate the therapeutic effect of regional arterial infusion (RAI) with Aspirin-Triggered Lipoxin A4 (ATL) in experimental severe acute pancreatitis (SAP) in rats.

Materials and methods: SAP was induced by injection of 5% sodium taurocholate into the pancreatic duct. Rats with SAP were treated with ATL (the ATL group) or physiological saline (the SAP group) infused via the left gastric artery 30 min after injection of sodium taurocholate. The sham group was subjected to the same surgical procedure, though without induction of SAP. Serum levels of amylase, phospholipase A2 (PLA2), interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNF-α) were measured at 12 and 24 h after induction of SAP. Ascitic fluid, the pancreatic index (wet weight ratio) and myeloperoxidase (MPO) levels in the pancreas were determined and histopathological findings were evaluated. The expression of intercellular adhesion molecule-1 (ICAM-1), platelet endothelial cell adhesion molecule-1 (PECAM-1), NF-κB p65, and heme oxygenase-1 (HO-1) in the pancreas were estimated by immunofluorescence and western blot, respectively.

Results: ATL rats had lower serum levels of TNF-α, IL-1β, and IL-6 (P<0.01), PLA2 (P<0.05), and amylase levels (P<0.05) studied as compared with the SAP group. The pancreatic index in the ATL group decreased only at 24 h as compared with the SAP group (P<0.05). The histopathological findings and MPO levels in the pancreas significantly decreased in the ATL group as compared to the SAP group (P<0.05 and P<0.01, respectively). Immunofluorescence and western blot showed that ATL attenuated the expression of NF-κB p65, ICAM-1 and PECAM-1 in the pancreas, and increased the expression of HO-1 in SAP animals.

Conclusions: We demonstrated that RAI with ATL attenuated the severity of experimental SAP, maybe achieved by improving the expression of HO-1, and down-regulating the NF-κB signaling pathway, with decreased expression of ICAM-1 and PECAM-1 and reduced generation of pro-inflammatory cytokines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amylases / blood
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Aspirin / pharmacology*
  • Cytokines / metabolism
  • Heme Oxygenase-1 / metabolism
  • Inflammation / blood
  • Inflammation / drug therapy*
  • Inflammation / pathology
  • Infusions, Intra-Arterial
  • Intercellular Adhesion Molecule-1 / metabolism
  • Interleukin-1beta / blood
  • Interleukin-6 / blood
  • Lipoxins / pharmacology*
  • Male
  • Pancreas / pathology
  • Pancreatitis / drug therapy*
  • Pancreatitis / pathology
  • Peroxidase / metabolism
  • Phospholipases A2 / blood
  • Platelet Endothelial Cell Adhesion Molecule-1 / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Taurocholic Acid
  • Transcription Factor RelA / metabolism
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cytokines
  • Interleukin-1beta
  • Interleukin-6
  • Lipoxins
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Rela protein, rat
  • Transcription Factor RelA
  • Tumor Necrosis Factor-alpha
  • lipoxin A4
  • Intercellular Adhesion Molecule-1
  • Taurocholic Acid
  • Peroxidase
  • Heme Oxygenase-1
  • Phospholipases A2
  • Amylases
  • Aspirin

Grants and funding

This study was supported by grants of the National Natural Science Foundation of China (Grant No. 81070372, No. 81370563), the Provincial Department of Construction Project (Grant No. WKJ2012-2-033), the Science and Technology Department Commonwealth Technology Applied Research Project of Zhejiang Province (Grant No. 2012C 23108), the Natural Science Foundation of Zhejiang Province (Grant No. LY12H03005, No. LY12H03007), the Excellent Youth Foundation of Zhejiang Provincial Natural Science (Grant No. LR14H030001), the Zhejaing Provincial Program for the Cultivation of High-level Innovative Health talents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.